Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Taiho Pharmaceutical
Deals
Taiho pays to claw back licensing rights to lung cancer med
Taiho is spending nearly $250 in upfront cash to claw back some licensing rights of its lung cancer med that's gearing up for a pivotal phase 2 trial.
Max Bayer
May 12, 2022 3:00am
Taiho Pharma, Cullinan Oncology join forces on EGFR drug
Feb 5, 2019 10:51am
Taiho swells its U.S.-based VC fund to $300M
Oct 16, 2018 8:28am
Chutes & Ladders—Biogen executive Kress heads Syntimmune
Jan 5, 2018 8:45am
